Roberto Bursi
Overview
Explore the profile of Roberto Bursi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cafaro G, Bursi R, Valentini V, Hansel K, Perricone C, Venerito V, et al.
Front Immunol
. 2025 Jan;
15:1505322.
PMID: 39877343
This pilot study investigates distinctive features within the nail-enthesis complex among Psoriatic arthritis (PsA), Psoriasis (PSO), Rheumatoid Arthrit is (RA), and Healthy Control (HC) groups, utilizing a combined approach of...
2.
Barbera L, Rizzo C, Camarda F, Atzeni F, Miceli G, Molica Colella A, et al.
Clin Exp Rheumatol
. 2024 Jan;
42(5):991-998.
PMID: 38197190
Objectives: We investigated the effectiveness and safety of filgotinib in a real-life multicentre cohort of rheumatoid arthritis (RA) patients. Methods: RA patients were evaluated at baseline and after 12 and...
3.
Perricone C, Cafaro G, Fiumicelli E, Bursi R, Bogdanos D, Riccucci I, et al.
Clin Exp Med
. 2022 Dec;
23(7):3391-3397.
PMID: 36566303
To date, few papers investigated the predictive factors of sustained 24-month remission and of flare in patients with polymyalgia rheumatica (PMR). We retrospectively evaluated clinical charts from PMR patients. Patients...
4.
Cafaro G, Perricone C, Bursi R, Riccucci I, Calvacchi S, Lomurno G, et al.
Clin Exp Rheumatol
. 2022 Oct;
40(12):2253-2257.
PMID: 36200944
Objectives: Salivary gland ultrasonography (SGUS) is commonly employed in the diagnosis and follow-up of patients with Sjögren's syndrome (SS) and multiple scoring systems have been developed to quantify the grade...
5.
Cafaro G, Bursi R, Chatzis L, Fulvio G, Ferro F, Bartoloni E, et al.
Clin Exp Rheumatol
. 2021 Dec;
39 Suppl 133(6):3-13.
PMID: 34874834
Sjögren's syndrome (SS) is a multifactorial systemic autoimmune disease of unknown aetiology characterised by a wide spectrum of different clinical manifestations and scattered complications. Recently, great efforts have been made...
6.
Cafaro G, Perricone C, Riccucci I, Bursi R, Calvacchi S, Alunno A, et al.
Clin Exp Rheumatol
. 2021 Oct;
39 Suppl 133(6):107-113.
PMID: 34665709
Objectives: Several cardiovascular (CV) risk algorithms are available to predict CV events in the general population. Their performance and validity in rheumatic disease patients is suboptimal as some disease-specific variables...
7.
Bursi R, Cafaro G, Perricone C, Riccucci I, Calvacchi S, Gerli R, et al.
Front Pharmacol
. 2021 Apr;
12:635663.
PMID: 33854436
Janus-kinase (JAK) and signal transduction activator of transcription (STAT) signal transduction pathway is involved in a wide range of physiological and pathological processes, including in the pathogenesis of several autoimmune...
8.
Perricone C, Triggianese P, Bursi R, Cafaro G, Bartoloni E, Chimenti M, et al.
Microorganisms
. 2021 Jan;
9(1).
PMID: 33430200
Intravenous immunoglobulins (IVIG) are blood preparations pooled from the plasma of donors that have been first employed as replacement therapy in immunodeficiency. IVIG interact at multiple levels with the different...
9.
Gatto M, Perricone C, Tonello M, Bistoni O, Cattelan A, Bursi R, et al.
Clin Exp Rheumatol
. 2020 Jul;
38(4):754-759.
PMID: 32723434
Objectives: COVID-19 features include disseminated intravascular coagulation and thrombotic microangiopathy indicating a hypercoagulable state. We aimed to investigate antiphospholipid antibodies (aPL) prevalence and clinical relationships in a large cohort of...
10.
Perricone C, Bartoloni E, Bursi R, Cafaro G, Guidelli G, Shoenfeld Y, et al.
Immunol Res
. 2020 Jul;
68(4):213-224.
PMID: 32681497
SARS-CoV-2 infection is characterized by a protean clinical picture that can range from asymptomatic patients to life-threatening conditions. Severe COVID-19 patients often display a severe pulmonary involvement and develop neutrophilia,...